Review
Published on 19 Oct 2022
A perspective on oligonucleotide therapy: Approaches to patient customization
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1006304
- 26,852 views
- 49 citations
Type at least 3 characters
3,258 articles
Articles
Original Research
Published on 19 Oct 2022
Caenorhabditis elegans as a valuable model for the study of anthelmintic pharmacodynamics and drug-drug interactions: The case of ivermectin and eprinomectin
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.984905
- 3,800 views
- 6 citations
Original Research
Published on 19 Oct 2022
Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1041331
- 2,318 views
- 5 citations
Original Research
Published on 18 Oct 2022
Single and combined impacts of irradiation and surgery on lymphatic vasculature and fibrosis associated to secondary lymphedema
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1016138
- 2,626 views
- 2 citations
Original Research
Published on 17 Oct 2022
Quercitrin neutralizes sPLA2IIa activity, reduces the inflammatory IL-6 level in PC3 cell lines, and exhibits anti-tumor activity in the EAC-bearing mice model
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.996285
- 2,131 views
- 8 citations
Systematic Review
Published on 17 Oct 2022
Alterations in bone fracture healing associated with TNFRSF signaling pathways
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.905535
- 2,889 views
- 2 citations
Brief Research Report
Published on 14 Oct 2022
Sustained MK-801 induced deficit in a novel probabilistic reversal learning task
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.898548
- 2,648 views
- 3 citations
Original Research
Published on 14 Oct 2022
LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.973612
- 4,276 views
- 6 citations
Original Research
Published on 14 Oct 2022
ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction via regulating ACE2 shedding and myofibroblast transformation
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.997916
- 2,896 views
- 8 citations
Original Research
Published on 14 Oct 2022
Oxysterols in catfish skin secretions (Arius bilineatus, Val.) exhibit anti-cancer properties
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1001067
- 2,035 views
- 3 citations
Original Research
Published on 14 Oct 2022
1,8-Cineole inhibits biofilm formation and bacterial pathogenicity by suppressing luxS gene expression in Escherichia coli
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.988245
- 3,787 views
- 11 citations
Original Research
Published on 14 Oct 2022
Study on the anti-biofilm mechanism of 1,8-cineole against Fusarium solani species complex
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1010593
- 2,024 views
- 6 citations
Original Research
Published on 14 Oct 2022
Predictive value of myocardial strain on myocardial infarction size by cardiac magnetic resonance imaging in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1015390
- 1,997 views
- 5 citations
Original Research
Published on 14 Oct 2022
Thermal proteome profiling reveals Haemonchus orphan protein HCO_011565 as a target of the nematocidal small molecule UMW-868
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1014804
- 3,161 views
- 11 citations
Original Research
Published on 14 Oct 2022
Novel ultrashort-acting benzodiazepine remimazolam lowers shivering threshold in rabbits
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1019114
- 2,370 views
- 1 citation
Editorial
Published on 14 Oct 2022
Editorial: Advances on targeted nanomedicines for atherosclerosis
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1053938
- 1,316 views